Newsroom Stories

​​Today’s U.S. Supreme Court decision in the Hobby Lobby case is the corporate equivalent of the road to Damascus, says Elizabeth Sepper, JD, associate professor of law at Washington University in St. Louis. “Many more corporations will find religion to opt out of regulation that affects their bottom line,” Sepper says. “Before Hobby Lobby, businesses lost claims to fire pregnant women, refuse to promote non-Christians, discriminate against gays, and pay below the minimum wage. “After Hobby Lobby, they seem likely to succeed.”​

Poor physical health and financial health are driven by the same underlying psychological factors, finds a new study from Olin Business School at Washington University in St. Louis.

Joseph Jez, PhD, co-director of the plant and microbial biosciences graduate program at Washington University in St. Louis, is one of 15 professors nationwide to receive a $1 million HHMI grant to bring the creativity he has shown in the lab to the undergraduate classroom. He plans to use the grant to establish a two-year program called the Biotech Explorers Pathway that will introduce entering students to both the science and business of biotechnology.

Colin Nichols, PhD, the Carl F. Cori Endowed Professor and director of the Center for the Investigation of Membrane Excitability Diseases, has been elected to the Royal Society, an honorary English organization equivalent to the National Academy of Sciences in the United States.

Hundreds of thousands of American youth are following marijuana-related Twitter accounts and getting pro-pot messages several times each day, according to researchers at the School of Medicine. They said the tweets are cause for concern because young people are thought to be especially responsive to social media influences and because patterns of drug use tend to be established in a person’s late teens and early 20s.

Matthew J. Matava, MD, has been recognized as one of the top knee surgeons in North America by Orthopedics This Week, a newsletter for professionals in the field.

A novel antibiotic delivery system would exploit small molecules called siderophores that bacteria secrete to scavenge for iron in their environments. Each bacterium has its own system of siderophores, which it pumps across its cell membrane before releasing the iron the siderophores hold. If an antibiotic were linked to one of these scavenger molecules, it would be converted into a tiny Trojan horse that would smuggle antibiotics inside a bacterium’s cell membrane.

New research from the School of Medicine raises the prospect that some cancer patients with aggressive tumors may benefit from a class of anti-inflammatory drugs currently in use against rheumatoid arthritis.

Signals from the immune system that help repel a common parasite inadvertently can cause a dormant viral infection to become active again, a new study from the School of Medicine shows. Pictured is a helminth parasite.

Vision researchers from 38 clinical sites, including the School of Medicine, have found that the eyesight of patients with an unusual vision disorder linked to obesity improves twice as much if they take a glaucoma drug and lose a modest amount of weight than if they only lose weight. Neuro-ophthalmologist Gregory Van Stavern, MD, led the study in St. Louis.